The Australian and New Zealand journal of psychiatry
April 28, 2025
Salam Hussain, Chris Gale, Shanthi Sarma et al.
10 citations
Professional practice guidelines for the use of ketamine in psychiatric practice have been developed by the Royal Australian and New Zealand College of Psychiatrists to provide guidance on the use of ketamine in clinical practice in Australia and Aotearoa New Zealand, based on scientific evidence and supplemented by expert clinical consensus. Articles and information were sourced from existing...
The Australian and New Zealand journal of psychiatry
April 1, 2025
Alene Sze Jing Yong, Suzie Bratuskins, Musa Samir Sultani et al.
16 citations
To critically evaluate published and unpublished systematic reviews and meta-analyses on the safety and efficacy of methylenedioxymethamphetamine-assisted psychotherapy for post-traumatic stress disorder. Six bibliometric databases and grey literature were searched from inception to 9 May 2024 for systematic reviews on the safety and efficacy of methylenedioxymethamphetamine (MDMA)-assisted...
The Australian and New Zealand journal of psychiatry
October 1, 2024
Zohaib Nadeem, Stephen Parker, Hugh McGovern et al.
19 citations
Despite rapid advances in psychedelic sciences and the increasing number of countries legalizing psychedelics for the treatment of mental illnesses, the attitudes, knowledge and readiness of both mental health consumers and the general population remain largely unknown. A cross-sectional survey was conducted among Australians, targeting individuals with mental illness as potential mental health...
The Australian and New Zealand journal of psychiatry
October 1, 2024
Alistair Carroll, Adam Bayes, Mark Montebello et al.
10 citations
Ketamine is a restricted and regulated medication in Australia and New Zealand, which has implications when considering treatment for patients with treatment-resistant depression and a history of illicit drug use, abuse or dependence. Regulations governing prescription of ketamine for treatment-resistant depression vary between jurisdictions in Australia and New Zealand, though most restrict...
The Australian and New Zealand journal of psychiatry
July 1, 2024
Nicollette Lr Thornton, Dean J Wright, Nick Glozier
5 citations
One could argue that we are living through a period of innovation and change in psychiatry unlike that seen before, with repurposed medications emerging as novel treatments. However, despite evidence of enhanced clinical outcomes and potential medium-term savings, delivering these promising interventions is resource-intensive and perceived as difficult in the public sector. Consequently, they...
The Australian and New Zealand journal of psychiatry
February 1, 2024
Anthony Rodgers, Dilara Bahceci, Christopher G. Davey et al.
8 citations
In this paper, the case study of ketamine as a new treatment for severe depression is used to outline the challenges of repurposing established medicines and we suggest potential solutions. The antidepressant effects of generic racemic ketamine were identified over 20 years ago, but there were insufficient incentives for commercial entities to pursue its registration, or support for...
The Australian and New Zealand journal of psychiatry
April 1, 2023
Gillinder Bedi, Susan M Cotton, Alexandre A. Guerin et al.
17 citations
Recent years have seen escalating media, public and scientific interest in psychedelic medicine. Australia and New Zealand have been late to this research; however, in the past 2 years, rapid developments suggest that this is changing. Here, we argue for the need to critically review existing evidence in this field to guide future directions. We focus on...
The Australian and New Zealand journal of psychiatry
May 2022
Wei Lin Toh, Mikaela Bere, Susan L Rossell
The study of hallucinations across multiple senses in psychosis has garnered renewed interest. Recent studies have adopted the term multimodal hallucinations to describe these experiences, yet some appear to be investigating a different, but related, phenomenon. In the current paper, we suggest use of the terms multimodal hallucinations and multisensory hallucinations to categorise distinct...
The Australian and New Zealand journal of psychiatry
October 2011
Andrea J Phelps, David Forbes, Malcolm Hopwood et al.
Consensus on the parameters of trauma-related dreams required to meet criteria for post-traumatic stress disorder (PTSD) is critical when: (i) the diagnosis requires a single re-experiencing symptom; and (ii) trauma dreams are prevalent in survivors without PTSD. This study investigated the phenomenology of PTSD dreams in 40 veterans, using structured interview and self-report measures. Dream...
The Australian and New Zealand journal of psychiatry
November 1, 2009
C Robert Cloninger
The functional structure of self-aware consciousness in human beings is described based on the evolution of human brain functions. Prior work on heritable temperament and character traits is extended to account for the quantum-like and holographic properties (i.e. parts elicit wholes) of self-aware consciousness. Cladistic analysis is used to identify the succession of ancestors leading to...
The Australian and New Zealand journal of psychiatry
October 1, 2007
John D. Sellman, Michael P Baker, Simon J Adamson et al.
The purpose of the present paper was to explore the concept and experience of God in relation to recovery from drug addiction from a scientific perspective. Examination of a diverse literature was undertaken, including five key threads: the universality of the experience of God; the induction of spiritual experiences of God through hallucinogenic drugs; the nature of drug addiction from an...
The Australian and New Zealand journal of psychiatry
April 2006
Nicholas B Allen, Richard Chambers, Wendy Knight
This paper, composed by an interest group of clinicians and researchers based in Melbourne, presents some background to the practice of mindfulness-based therapies as relevant to the general professional reader. We address the empirical evidence for these therapies, the principles through which they might operate, some practical questions facing those wishing to commence practice in this area...
The Australian and New Zealand journal of psychiatry
February 1, 2000
W Hall, L Degenhardt
This paper evaluates evidence for two hypotheses about the relationship between cannabis use and psychosis: (i) that heavy cannabis use causes a 'cannabis psychosis', i.e. a psychotic disorder that would not have occurred in the absence of cannabis use and which can be recognised by its pattern of symptoms and their relationship to cannabis use; and (ii) that cannabis use may precipitate...
The Australian and New Zealand journal of psychiatry
August 1996
P Brown, M B Macmillan, R Meares et al.
Interest in the work of Pierre Janet is presently undergoing a scholarly revival and, in the process, his contribution to dynamic psychiatry is increasingly being recognised. This article compares and contrasts Pierre Janet's early studies on hysteria and the neuroses with those of Freud. The study surveys original works by Janet and Freud and contemporary scholarly exegeses. It particularly...
The Australian and New Zealand journal of psychiatry
December 1990
T Heins, A Gray, M Tennant
Hallucinations can persist for many years after childhood sexual abuse. If we recognise this, we will not mis-diagnose psychosis and we may treat with psychotherapy (talk). The hallucinations are distinct from hallucinations in schizophrenia though patients have frequently been given that diagnosis. They would generally be classified as pseudo-hallucinations. They are generally...
The Australian and New Zealand journal of psychiatry
June 1986
R R Kydd, J J Wright
This paper examines the classical functions of the psyche--cognition, affection and conation--from a phenomenological viewpoint and finds them to be defined each in terms of the other. It is held that this circularity of definition reflects the fundamental unity of conscious experience and, as a consequence, that the search for the biological substrate underlying individual functions too...
The Australian and New Zealand journal of psychiatry
September 1, 1985
W H Wessels
29 citations
Successful psychiatric treatment for rural Africans should incorporate their traditional belief that illness should be viewed in terms of magical, social, physical and religious parameters. Traditional healers divide illness into those of natural causation and those of traditional cultural aetiology which are peculiar to African people. Natural illness includes epilepsy, familial/genetic...
The Australian and New Zealand journal of psychiatry
March 1, 1985
J Cawte
91 citations
Before white man brought his alcohol to the South Pacific, the indigenes were using many wild plants possessing psychoactive properties. The most prominent were betel in much of Melanesia, kava in much of Polynesia, and pituri in much of Australia. The use of each of these three drugs was widespread, institutionalised as a ritual and the occasion for extensive trade. Each was valued for its...
The Australian and New Zealand journal of psychiatry
September 1983
N Buhrich, G Morris, G Cook
If the frequency of seizures by police of hallucinogens reflects the frequency with which various hallucinogens are ingested in Australasia, most toxic states resulting from hallucinogen abuse are due to Bromo-DMA and not to LSD as is commonly reported by the subjects. Two cases of intoxication with the new hallucinogen, Bromo-DMA, are reported. Both recovered within 24 hours following...
The Australian and New Zealand journal of psychiatry
June 1, 1976
C P Wijesinghe, S A Dissanayake, N Mendis
27 citations
A survey of possession trance states in a semi-urban population of 7653 identified 37 subjects. The manifestations of the trance, and its course and outcome are outlined. The characteristics of the subjects, including presence of psychiatric disorder, are compared with that of the total population, and significant differences are noted. Four psychodynamic syndromes observed are described with...